Dysfunction of S100A4+ effector memory CD8+ T cells aggravates asthma
- Eur J Immunol. 2022 Jun;52(6):978-993. doi: 10.1002/eji.202149572.
- 1. Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
- 2. Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
- 3. University of Chinese Academy of Sciences, Beijing, China.
- 4. Priority Research Centre for Healthy Lungs, School of Biomedical Sciences & Pharmacy, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia.
- 5. German Rheumatism Research Center (DRFZ), Leibniz Institute, Berlin, Germany.
Progressive loss of effector functions, especially IFN-γ secreting capability, in effector memory CD8+ T (CD8+ TEM ) cells plays a crucial role in asthma worsening. However, the mechanisms of CD8+ TEM cell dysfunction remain elusive. Here, we report that S100A4 drives CD8+ TEM cell dysfunction, impairing their protective memory response and promoting asthma worsening in an ovalbumin (OVA)-induced asthmatic murine model. We find that CD8+ TEM cells contain two subsets based on S100A4 expression. S100A4+ subsets exhibit dysfunctional effector phenotypes with increased proliferative capability, whereas S100A4- subsets retain effector function but are more inclined to Apoptosis, giving rise to a dysfunctional CD8+ TEM cell pool. Mechanistically, S100A4 upregulation of Mitochondrial Metabolism results in a decrease of acetyl-CoA levels, which impair the transcription of effector genes, especially IFN-γ, facilitating cell survival, tolerance, and memory potential. Our findings thus reveal general insights into how S100A4+ CD8+ TEM cells reprogram into dysfunctional and less protective phenotypes to aggravate asthma.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Mitochondrial MetabolismResearch Areas: Cancer